These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11856330)

  • 1. Anti-(Raf-1) RNA aptamers that inhibit Ras-induced Raf-1 activation.
    Kimoto M; Shirouzu M; Mizutani S; Koide H; Kaziro Y; Hirao I; Yokoyama S
    Eur J Biochem; 2002 Jan; 269(2):697-704. PubMed ID: 11856330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA aptamers that specifically bind to the Ras-binding domain of Raf-1.
    Kimoto M; Sakamoto K; Shirouzu M; Hirao I; Yokoyama S
    FEBS Lett; 1998 Dec; 441(2):322-6. PubMed ID: 9883908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformation-specific inhibitors of activated Ras GTPases reveal limited Ras dependency of patient-derived cancer organoids.
    Wiechmann S; Maisonneuve P; Grebbin BM; Hoffmeister M; Kaulich M; Clevers H; Rajalingam K; Kurinov I; Farin HF; Sicheri F; Ernst A
    J Biol Chem; 2020 Apr; 295(14):4526-4540. PubMed ID: 32086379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear magnetic resonance and molecular dynamics studies on the interactions of the Ras-binding domain of Raf-1 with wild-type and mutant Ras proteins.
    Terada T; Ito Y; Shirouzu M; Tateno M; Hashimoto K; Kigawa T; Ebisuzaki T; Takio K; Shibata T; Yokoyama S; Smith BO; Laue ED; Cooper JA
    J Mol Biol; 1999 Feb; 286(1):219-32. PubMed ID: 9931261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point mutants of c-raf-1 RBD with elevated binding to v-Ha-Ras.
    Fridman M; Maruta H; Gonez J; Walker F; Treutlein H; Zeng J; Burgess A
    J Biol Chem; 2000 Sep; 275(39):30363-71. PubMed ID: 10887184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
    Okazaki M; Kishida S; Murai H; Hinoi T; Kikuchi A
    Cancer Res; 1996 May; 56(10):2387-92. PubMed ID: 8625316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solution structure of the Ras-binding domain of RGL.
    Kigawa T; Endo M; Ito Y; Shirouzu M; Kikuchi A; Yokoyama S
    FEBS Lett; 1998 Dec; 441(3):413-8. PubMed ID: 9891982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular dynamics simulations of the Ras:Raf and Rap:Raf complexes.
    Zeng J; Treutlein HR; Simonson T
    Proteins; 1999 Apr; 35(1):89-100. PubMed ID: 10090289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KRAS interaction with RAF1 RAS-binding domain and cysteine-rich domain provides insights into RAS-mediated RAF activation.
    Tran TH; Chan AH; Young LC; Bindu L; Neale C; Messing S; Dharmaiah S; Taylor T; Denson JP; Esposito D; Nissley DV; Stephen AG; McCormick F; Simanshu DK
    Nat Commun; 2021 Feb; 12(1):1176. PubMed ID: 33608534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Raf-1 RBD associates with a subset of active v-H-Ras.
    Fridman M; Walker F; Catimel B; Domagala T; Nice E; Burgess A
    Biochemistry; 2000 Dec; 39(50):15603-11. PubMed ID: 11112548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural determinants of Ras-Raf interaction analyzed in live cells.
    Bondeva T; Balla A; Várnai P; Balla T
    Mol Biol Cell; 2002 Jul; 13(7):2323-33. PubMed ID: 12134072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure determination of the Ras-binding domain of the Ral-specific guanine nucleotide exchange factor Rlf.
    Esser D; Bauer B; Wolthuis RM; Wittinghofer A; Cool RH; Bayer P
    Biochemistry; 1998 Sep; 37(39):13453-62. PubMed ID: 9753431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing the effects of physiologically-based metal oxide nanoparticles on ribonucleic acid and RAS/RBD-targeted triplex and aptamer interactions.
    Huslig G; Marchell N; Hoffman A; Park S; Choi SO; DeLong RK
    Biochem Biophys Res Commun; 2019 Sep; 517(1):43-48. PubMed ID: 31307783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transition state of the ras binding domain of Raf is structurally polarized based on Phi-values but is energetically diffuse.
    Campbell-Valois FX; Michnick SW
    J Mol Biol; 2007 Feb; 365(5):1559-77. PubMed ID: 17137592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro inhibition of Ras-Raf association by short peptides.
    Barnard D; Sun H; Baker L; Marshall MS
    Biochem Biophys Res Commun; 1998 Jun; 247(1):176-80. PubMed ID: 9636675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of B-Raf in Ras-induced Raf-1 activation.
    Mizutani S; Inouye K; Koide H; Kaziro Y
    FEBS Lett; 2001 Nov; 507(3):295-8. PubMed ID: 11696358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the guanine nucleotide dissociation stimulator for Ral as a putative effector molecule of R-ras, H-ras, K-ras, and Rap.
    Spaargaren M; Bischoff JR
    Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12609-13. PubMed ID: 7809086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection and characterisation of affibody molecules inhibiting the interaction between Ras and Raf in vitro.
    Grimm S; Lundberg E; Yu F; Shibasaki S; Vernet E; Skogs M; Nygren PÅ; Gräslund T
    N Biotechnol; 2010 Dec; 27(6):766-73. PubMed ID: 20674812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B- and C-RAF display essential differences in their binding to Ras: the isotype-specific N terminus of B-RAF facilitates Ras binding.
    Fischer A; Hekman M; Kuhlmann J; Rubio I; Wiese S; Rapp UR
    J Biol Chem; 2007 Sep; 282(36):26503-16. PubMed ID: 17635919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-mutant analysis of the interaction of Ras with the Ras-binding domain of RGL.
    Shirouzu M; Hashimoto K; Kikuchi A; Yokoyama S
    Biochemistry; 1999 Apr; 38(16):5103-10. PubMed ID: 10213614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.